- Home
- VEL vs CMPS Comparison
VEL vs CMPS Comparison
Compare VEL & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VEL | CMPS |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 765.5M | 724.5M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VEL | CMPS |
|---|---|---|
| Price | $19.43 | $9.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $22.00 | ★ $26.57 |
| AVG Volume (30 Days) | 80.6K | ★ 4.3M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.98 | N/A |
| EPS | ★ 2.75 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.01 | N/A |
| Revenue Next Year | $19.02 | N/A |
| P/E Ratio | $7.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.12 | $2.25 |
| 52 Week High | $21.40 | $10.21 |
Technical Indicators
Market Signals| Indicator | VEL | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 74.48 |
| Support Level | $19.37 | $4.56 |
| Resistance Level | $21.12 | N/A |
| Average True Range (ATR) | 0.50 | 0.63 |
| MACD | 0.05 | 0.44 |
| Stochastic Oscillator | 68.25 | 84.90 |
Price Performance
Historical ComparisonAbout VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.